[{"Assets_0_Q3_USD":259123000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-101776000.0,"NetIncomeLoss_1_Q3_USD":-39694000.0,"NetIncomeLoss_3_Q3_USD":-103228000.0,"StockholdersEquity_0_Q3_USD":-67423000.0,"EarningsPerShareBasic_1_Q3_USD":-1.32,"EarningsPerShareBasic_3_Q3_USD":-3.44,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":30110391.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":30004211.0,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]